# Adult SMA Research and Clinical Hub

> **NCT06978985** · — · RECRUITING · sponsor: **Newcastle-upon-Tyne Hospitals NHS Trust** · enrollment: 600 (estimated)

## Conditions studied

- Spinal Muscular Atrophy (SMA)

## Interventions

- **DRUG:** Risdiplam
- **DRUG:** Nusinersen Injectable Product

## Key facts

- **NCT ID:** NCT06978985
- **Lead sponsor:** Newcastle-upon-Tyne Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-29
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-04-30
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06978985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06978985, "Adult SMA Research and Clinical Hub". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06978985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*